How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...

Losing: A film that does not recover the investment but loses less than 50% of it Flop: Film that loses 50% or more of its investment * denotes that the film is still running in theatres. Explore how ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Days after No. 1 senior Tyran Stokes committed to Kansas, we released what we thought would be our final recruiting class rankings of the 2026 cycle. Given the neverending nature of roster ...